Abstract

The immunomodulator AS101 has been previously shown to confer protection upon BALB/c mice infected with the intraerythrocytic parasiteBabesia rodhaini (B. rodhaini).The present study focuseson the effect of AS101 administration on the acute phase of babesial infection where T helper cellsubset patterns—TH1/TH2—were assessed in heavily infected mice. Secretion of cytokines of the TH1subset (IL-2, IFN-γ, IL-12) and of the TH2subset (IL-10, IL-4) as well as TGF-β was measured following the administration of AS101 2 weeks before parasiteinfection. Our results demonstrate that the parasites suppress IL-2 protein and IL-12 mRNA andthat AS101 upregulates their secretion: IL-2, 8 u/ml vs 34 u/ml, respectively; IFN-γ protein, 2370 pg/ml vs 4777 pg/ml, respectively. Conversely, babesial infection results in the upregulation of IL-10 and IL-4 proteins and TGF-β transcripts, whereas AS101 downregulates their production: IL-10, 1800 pg/mlvs 360 pg/ml, respectively; IL-4, 58.3 pg/ml vs 24.5 pg/ml, respectively. A possible escape mechanisminduced byB. rodhainiis suggested, starting with IL-10 inhibition of macrophage activities leadingto a suppression of the TH1response and of IL-2in particular. It is therefore possible that AS101may protect infected mice by activating cellular-mediated immunity and concurrently balancing the THsubset responses. It is suggested that AS101 may be effective as an antiparasitic drug.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.